Skip to Content

382 (Quetiapine Fumarate Extended-Release 200 mg)

Pill with imprint 382 is Yellow, Capsule-shape and has been identified as Quetiapine Fumarate Extended-Release 200 mg. It is supplied by ScieGen Pharmaceuticals, Inc..

Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; schizophrenia; depression; major depressive disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 382

Quetiapine Fumarate Extended-Release

Imprint
382
Strength
200 mg
Color
Yellow
Size
17.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
ScieGen Pharmaceuticals, Inc.
National Drug Code (NDC)
50228-0382
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, trisodium citrate dihydrate, magnesium stearate, polyethylene glycol 400, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "382"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.